Dr. Alessandro Mattina (Chief of the Diabetes Service, IRCCS ISMETT | UPMC
and Clinical Assistant Professor of Medicine, University of Pittsburgh School of Medicine) is a specialist in Internal Medicine with clinical and research expertise in metabolism, diabetes, and lipid disorders. He trained as a Clinical Research Fellow at Hôpital Pitié-Salpêtrière (Paris) - Endrocrinology, Metabolism and Cardiovascular Prevention Unit - and completed academic courses at Sorbonne Université. He earned a PhD in Cardiovascular, Metabolic, and Degenerative Diseases from the University of Palermo, focusing on dyslipidemias, insulin resistance, and obesity.
Since 2018, he has worked at IRCCS ISMETT as a diabetologist and clinical lead of the pancreas and kidney-pancreas transplant program. His interests include post-transplant diabetes, type 1 and 2 diabetes, and islet/pancreas transplantation.
In 2024, he was appointed Clinical Assistant Professor at the University of Pittsburgh. He serves as Principal Investigator in research on diabetes and MASLD and is active in international networks, contributing as author, reviewer, and editorial board member.
Dr. Alessandro Mattina (Chief of the Diabetes Service, IRCCS ISMETT | UPMC
and Clinical Assistant Professor of Medicine, University of Pittsburgh School of Medicine) is a specialist in Internal Medicine with clinical and research expertise in metabolism, diabetes, and lipid disorders. He trained as a Clinical Research Fellow at Hôpital Pitié-Salpêtrière (Paris) - Endrocrinology, Metabolism and Cardiovascular Prevention Unit - and completed academic courses at Sorbonne Université. He earned a PhD in Cardiovascular, Metabolic, and Degenerative Diseases from the University of Palermo, focusing on dyslipidemias, insulin resistance, and obesity.
Since 2018, he has worked at IRCCS ISMETT as a diabetologist and clinical lead of the pancreas and kidney-pancreas transplant program. His interests include post-transplant diabetes, type 1 and 2 diabetes, and islet/pancreas transplantation.
In 2024, he was appointed Clinical Assistant Professor at the University of Pittsburgh. He serves as Principal Investigator in research on diabetes and MASLD and is active in international networks, contributing as author, reviewer, and editorial board member.